转移BAN-Syn:一种基于转移学习的算法,用于预测抗球菌病的协同药物组合
Haitao Li1,2, Yuanyuan Chu1,2, Liyuan Jiang1,2
1Key Laboratory of Intelligent Computing and Signal Processing, School of Artificial Intelligence, Anhui University, Hefei, China.
Frontiers in genetics
|January 21, 2025
概括
这项研究介绍了TransferBAN-Syn,一种新的转移学习模型,用于识别用于球菌病 (一种寄生虫疾病) 的有效药物组合. 它通过利用来自其他寄生病的信息来克服数据稀缺性,改善治疗预测.
科学领域:
- 寄生虫学的寄生虫学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 脊髓灰质炎是一种重要的动物性寄生虫病,需要有效的治疗方法.
- 药物联合治疗对于克服药物耐药性和提高杆菌病的疗效至关重要.
- 鉴定药物组合的传统实验方法效率低下,成本高昂,对球菌可获得的数据有限.
研究的目的:
- 开发一种计算模型,用于识别对抗甲菌病的协同药物组合.
- 通过采用转移学习来应对角球菌病中药物组合数据有限的挑战.
- 提供一种新的计算方法,用于预测缺乏数据的疾病的药物对.
主要方法:
- 开发了一个基于转移学习的模型,TransferBAN-Syn.
- 该模型利用双线性注意网络来深度提取药物相互作用的特征.
- 转移BAN-Syn在21种寄生病 (源域) 的数据集上进行了训练,并对球菌病 (目标域) 进行了微调.
主要成果:
- 转移BAN-Syn显著提高了预测球菌病协同药物组合的准确性.
- 与传统方法相比,该模型显示了增强的通用性.
- 该研究确定了用于治疗球菌病的有希望的新药组合.
结论:
- 转移BAN-Syn提供了一种强大而准确的计算方法,用于发现球菌中协同作用的药物组合.
- 这种转移学习策略有效地克服了对罕见或研究不足的疾病药物发现的数据限制.
- 该模型为推进角球菌病治疗提供了有价值的工具,并为其他疾病的类似挑战提供了蓝图.
相关概念视频
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:27Combined Effects of Drugs: Synergism
7.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.7K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
01:29Pharmacogenomics: Identification of New Drug Targets
88
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
89
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
89
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
72
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
72